In addition to his work as is president of commercial operations at Mission Pharmacal Company, Terrell Herring takes an active role in a number of the company’s subsidiaries, including Alamo Pharma Services, BioComp Pharmaceuticals, and ProSolus Pharma. In addition, Terrell Herring is involved in the Mission Family of Companies’ support of the March of Dimes, an organization that works to reduce premature birth rates.
Recently, the March of Dimes teamed with the Centers for Disease Control and Prevention (CDC) to improve health for children exposed to drugs before birth. The partnership will look at Vermont, Illinois, and New Mexico, the three states with the highest incidence of neonatal abstinence syndrome (NAS), to evaluate the services that these children most need in their first months of life. When infants start their lives in withdrawal, they face a number of challenges. Understanding their needs can help ensure recovery.
In addition, these three states will gain valuable insight on why so many babies are being born exposed to drugs in the neonatal environment. This awareness could help create new programs and resources for women who are pregnant. Both organizations hope that the lessons learned in these three states will help other mothers and children across the nation.v